Molecular determinants of chemotherapy resistance in ovarian cancer

被引：7
|
作者：
Cooley, Megan [1 ]
Fang, Pingping [1 ]
Fang, Fang [2 ]
Nephew, Kenneth P. [2 ]
Chien, Jeremy [1 ]
机构：
[1] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA
[2] Indiana Univ, Dept Cellular & Integrat Physiol, Med Sci Program, Bloomington, IN 47405 USA
来源：
PHARMACOGENOMICS | 2015年 / 16卷 / 16期
关键词：
cancer genomics; chemotherapy; functional genomics; heterogeneity; intra-tumor; ovarian cancer; resistance; CPG ISLAND METHYLATION; DRUG-RESISTANCE; DNA METHYLATION; EXPRESSION; CISPLATIN; MECHANISMS; PLATINUM; CHEMORESISTANCE; HETEROGENEITY; EVOLUTION;
D O I：
10.2217/pgs.15.130
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1763 / 1767
页数：5
相关论文
共 50 条
  • [21] Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies
    P A Vasey
    British Journal of Cancer, 2003, 89 : S23 - S28
  • [22] Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies
    Vasey, PA
    BRITISH JOURNAL OF CANCER, 2003, 89 (Suppl 3) : S23 - S28
  • [23] Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapy
    Kurzeder, Christian
    Sauer, Georg
    Deissler, Helmut
    CURRENT CANCER DRUG TARGETS, 2006, 6 (03) : 207 - 227
  • [24] Role of cancer stem cells and microRNA in resistance to chemotherapy in patients with ovarian cancer
    Markowska, A.
    Sajdak, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (02) : 181 - 183
  • [25] Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy
    Masamha, Chioniso P.
    LaFontaine, Patrick
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (07) : 6136 - 6145
  • [26] Clinical and molecular features of platinum resistance in ovarian cancer
    Miras, Isabel
    Estevez-Garcia, Purificacion
    Munoz-Galvan, Sandra
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 201
  • [27] Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy
    Makovec, Tomaz
    RADIOLOGY AND ONCOLOGY, 2019, 53 (02) : 148 - 158
  • [28] Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer
    Borley, Jane
    Brown, Robert
    ANNALS OF MEDICINE, 2015, 47 (05) : 359 - 369
  • [29] DNA methylation characteristics associated with chemotherapy resistance in epithelial ovarian cancer
    Duan, Changling
    Yan, Zhongxin
    Wu, Cailiang
    Zhou, Xuexin
    Bao, Wei
    HELIYON, 2024, 10 (05)
  • [30] Expression of resistance gene and prognosis of chemotherapy in primary epithelial ovarian cancer
    Yang, Fengmei
    Gao, Bo
    Chen, Wei
    Du, Enfu
    Liang, Yong
    Hu, Xiuxue
    Yang, Xiaofeng
    MEDICINE, 2018, 97 (41)
12345